CAS 1423186-80-4

RIP2 kinase inhibitor 1

CAS: 1423186-80-4

Formel: C₂₁H₂₂N₄O₄S₂

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 458.5538

Ref: IN-DA009CNP

GSK2983559 active metabolite

CAS: 1423186-80-4

GSK2983559 active metabolite

Reinheit: ≥95%

Molekulargewicht: 458.55g/mol

Ref: 54-BUP04723

GSK2983559 active metabolite

CAS: 1423186-80-4

GSK2983559 active metabolite (RIPK2-IN-1) is a potent, selective receptor-interacting protein-2 (RIP2) kinase inhibitor.

Formel: C₂₁H₂₂N₄O₄S₂

Reinheit: 97.07% - 99.57%

Farbe und Form: Solid

Molekulargewicht: 458.55

Ref: TM-T5401

GSK2983559 active metabolite

CAS: 1423186-80-4

GSK2983559 is an investigative compound, which is a small-molecule therapeutic derived from pharmaceutical research. This compound is synthesized through advanced medicinal chemistry techniques employed by GlaxoSmithKline (GSK) to target specific biological mechanisms. The active metabolite of GSK2983559 exerts its effects primarily by modulating molecular pathways involved in inflammation, specifically inhibiting certain immune cell signaling cascades.

Formel: C₂₁H₂₂N₄O₄S₂

Reinheit: Min. 95%

Molekulargewicht: 458.55 g/mol

Ref: 3D-YGC18680